Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 74.30
-2.10 (-2.75%)
Sep 10, 2026, 11:59 AM HKT
Keymed Biosciences Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Keymed Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $103.93. The average 1-year stock price forecast is 39.88% higher than the current stock price, while the lowest is $90.36 (+21.62%) and the highest is $119.15 (+60.36%).
Price Target: $103.93 (+39.88%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Keymed Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 6 | 7 | 8 | 10 |
| Buy | 3 | 3 | 4 | 4 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 10 | 11 | 13 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $90.37 | Buy | Maintains | $90.37 | +21.63% | Aug 26, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $98.00 | Buy | Maintains | $98.00 | +31.90% | Aug 25, 2026 |
Unknown Analyst SPDB No rating | SPDB | Buy Maintains $108.30 | Buy | Maintains | $108.30 | +45.76% | Aug 25, 2026 |
Unknown Analyst Daiwa No rating | Daiwa | Buy Maintains $101.00 | Buy | Maintains | $101.00 | +35.94% | Aug 12, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $138.91 | Buy | Maintains | $138.91 | +86.96% | Jul 10, 2026 |
Financial Forecast
Revenue This Year
1.31B
from 716.31M
Increased by 82.97%
Revenue Next Year
2.15B
from 1.31B
Increased by 63.73%
EPS This Year
3.27
from -1.81
EPS Next Year
0.39
from 3.27
Decreased by -87.97%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.